Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.300
0.00 (0.00%)
May 29, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 50.13 million as of May 30, 2025. Its market cap has increased by 24.01% in one year.
Market Cap
50.13M
Enterprise Value
21.78M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 50.13M, an increase of 212.55%. That is a compound annual growth rate of 6.19%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 70.43B |
| Danel (Adir Yeoshua) | 2.38B |
| Kamada | 1.38B |
| Bait Bakfar | 1.16B |
| SofWave Medical | 729.99M |
| BrainsWay | 705.48M |
| Novolog (Pharm-Up 1966) | 701.90M |
| Ilex Medical | 693.44M |